CHARLES RIVER ASSOCIATES (CRA) REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026

CRA INTERNATIONAL, INC. (CRAI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contacts: Eric Nierenberg Nicholas Manganaro Charles River Associates Sharon Merrill Advisors investor@crai.com crai@investorrelations.com 617-425-3020 617-542-5300 CHARLES RIVER ASSOCIATES (CRA) REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026 Broad-based Rev

Event · Earnings
Also in this documentGuidance · raise · $830M–$840MDividend · increase · $0.67

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 5, 2026, 1:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CRAI
Bullish
high confidence
Mentioned
$CRAI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CRAIBullishHigh
01

Why it matters

The earnings beat and raised guidance are likely to attract buying interest, especially given the dividend hike.

02

Market read

First‑report earnings with material beat and guidance raise for a Nasdaq‑listed firm, offering a clear trading catalyst.

03

What to watch

Constant‑currency adjustments and increased loan amortization may dampen net income growth.

Relevance 7/10Novelty 8/10Timing: today
AlphAI · Earnings readCRAI · Third quarter fiscal 2026 · ended October 3, 2026

Broad-based Revenue Growth Drives Company’s Best-Ever Third-Quarter Results

✓Strong quarter

Third-quarter revenue grew 15.6% year over year to $214.9 million, GAAP net income increased 21.2% to $13.9 million, and CRA increased its full-year constant-currency revenue guidance to $830 million to $840 million.

Revenue
$215M
15.6% y/y
EPS · non-GAAP
$2.19
6.3% y/y
Full-year fiscal 2026, on a constant currency basis relative to fiscal 2025 outlook
$830 million to $840 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, fiscal quarter ended October 3, 2026GAAP$214.9M–15.6%
Revenue, fiscal year-to-date period ended October 3, 2026GAAP$626.7M––
Costs of services (exclusive of depreciation and amortization), fiscal quarter ended October 3, 2026GAAP$152.4M––
Selling, general and administrative expenses, fiscal quarter ended October 3, 2026GAAP$35.41M––
Selling, general and administrative expenses, fiscal year-to-date period ended October 3, 2026GAAP$105.2M––
Depreciation and amortization, fiscal quarter ended October 3, 2026GAAP$3.24M––
Income from operations, fiscal quarter ended October 3, 2026GAAP$23,893 (in thousands), or 11.1% of revenue––
Income from operations, fiscal year-to-date period ended October 3, 2026GAAP$65,466 (in thousands), or 10.4% of revenue––
Interest expense, net, fiscal quarter ended October 3, 2026GAAP−$2.61M––
Foreign currency gains (losses), net, fiscal quarter ended October 3, 2026GAAP$59K––
Provision for income taxes, fiscal quarter ended October 3, 2026GAAP$7.44M––
Net income, fiscal quarter ended October 3, 2026GAAP$13.9 million, or 6.5% of revenue–21.2%
Net income, fiscal year-to-date period ended October 3, 2026GAAP$38,546 (in thousands), or 6.2% of revenue––
Basic earnings per share, fiscal quarter ended October 3, 2026GAAP$2.21––
Diluted earnings per share, fiscal quarter ended October 3, 2026GAAP$2.20–27.2%
Diluted earnings per share, fiscal year-to-date period ended October 3, 2026GAAP$5.98––
Non-GAAP net income, fiscal quarter ended October 3, 2026non-GAAP$13.9 million, or 6.4% of revenue–1.5%
Non-GAAP net income, fiscal year-to-date period ended October 3, 2026non-GAAP$40,824 (in thousands), or 6.5% of revenue––
Non-GAAP diluted earnings per share, fiscal quarter ended October 3, 2026non-GAAP$2.19–6.3%
Non-GAAP diluted earnings per share, fiscal year-to-date period ended October 3, 2026non-GAAP$6.33––
Non-GAAP EBITDA, fiscal quarter ended October 3, 2026non-GAAP$27.1 million, or 12.6% of revenue–11.2%
Non-GAAP EBITDA, fiscal year-to-date period ended October 3, 2026non-GAAP$77,135 (in thousands), or 12.3% of revenue––
Utilization, fiscal quarter ended October 3, 2026other78%––
Quarter-end consultant headcount, fiscal quarter ended October 3, 2026other.–6.2% year over year

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Full-year fiscal 2026, on a constant currency basis relative to fiscal 2025 outlook

  • Revenue$830 million to $840 million
  • NoteNon-GAAP EBITDA margin in the range of 12.2% to 12.8%.
  • NoteThe constant currency adjustment will decrease CRA’s reported annual revenue by approximately $2.9 million.
  • NoteThe constant currency adjustment will decrease CRA’s reported annual EBITDA by approximately $0.4 million.
  • NoteNon-cash forgivable loan amortization is expected to increase in fiscal 2026 by approximately $15 million.
  • NoteApproximately $14 million of the increase in non-cash forgivable loan amortization has been booked through the first three quarters of fiscal 2026.

Capital returns

  • CRA returned $3.6 million of capital to its shareholders via dividend payments.
  • Quarterly cash dividend increased by 17.5% from $0.57 to $0.67 per common share.
  • The $0.67 per common share dividend is payable on December 11, 2026 to shareholders of record as of November 24, 2026.
  • Cash dividends and dividend equivalents paid were $11,040 (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $10,098 (in thousands).
  • Repurchase of common stock was $(49,303) (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $(47,149) (in thousands).

What drove it

  • Seven practices grew year over year, representing approximately 95% of the company’s total revenue for the third quarter.
  • Forensic Services, Life Sciences, and Risk, Investigations & Analytics each posted double-digit revenue growth year over year.
  • Antitrust & Competition Economics posted a new high for quarterly revenue.
  • Legal & Regulatory offerings grew 15.7% year over year, while Management Consulting services increased 9.8%.
  • North American operations increased by 18.0% and international operations grew 6.2% year over year.
  • On a constant currency basis relative to the third quarter of fiscal 2025, revenue would have been higher by $0.3 million.

Concerns

  • Non-GAAP EBITDA margin was 12.6% of revenue in the third quarter of fiscal 2026, compared with 13.1% in the third quarter of fiscal 2025.
  • Net cash used in operating activities was $(43,910) (in thousands) for the fiscal year-to-date period ended October 3, 2026.
  • Accounts receivable and unbilled services, net were $289,574 (in thousands) at October 3, 2026.
  • Management expects non-cash forgivable loan amortization to increase in fiscal 2026 by approximately $15 million, reflecting investments in talent to drive profitable growth.
  • Fiscal 2026 returns to CRA’s typical 52-week year, whereas fiscal 2025 contained an extra week in the fourth quarter and resulted in a 53-week year.

What to watch

  • Execution against full-year constant-currency revenue guidance of $830 million to $840 million and non-GAAP EBITDA margin guidance of 12.2% to 12.8%.
  • The expected approximately $2.9 million decrease in reported annual revenue and approximately $0.4 million decrease in reported annual EBITDA from the constant currency adjustment.
  • The expected approximately $15 million increase in non-cash forgivable loan amortization, of which approximately $14 million has been booked through the first three quarters of fiscal 2026.
  • Utilization, consultant headcount growth, and the company’s healthy sales pipeline.
  • Collections and working-capital trends, given the $289,574 (in thousands) accounts receivable and unbilled services balance and $(43,910) (in thousands) of year-to-date operating cash flow.

Balance sheet and cash flow

  • Cash and cash equivalents were $20,400 (in thousands) at October 3, 2026, compared with $18,210 (in thousands) at January 3, 2026.
  • Accounts receivable and unbilled services, net were $289,574 (in thousands) at October 3, 2026, compared with $248,862 (in thousands) at January 3, 2026.
  • Revolving line of credit was $75,000 (in thousands) at October 3, 2026, compared with $34,000 (in thousands) at January 3, 2026.
  • Non-current portion of term loan was $72,923 (in thousands) at October 3, 2026, compared with $0 (in thousands) at January 3, 2026.
  • Net cash used in operating activities was $(43,910) (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $(37,595) (in thousands).
  • Purchases of property and equipment, net were $(5,485) (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $(2,813) (in thousands).
  • Net cash provided by financing activities was $52,096 (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $34,891 (in thousands).

Analysis

CRA reported a record third quarter, with revenue rising 15.6% year over year to $214.9 million. GAAP net income increased 21.2% to $13.9 million and diluted earnings per share increased 27.2% to $2.20. Revenue growth was broad based: seven practices grew and represented approximately 95% of third-quarter revenue, while Legal & Regulatory grew 15.7% and Management Consulting grew 9.8%. North America grew 18.0% and international operations grew 6.2%.

Profitability improved on a GAAP basis, with income from operations of $23,893 (in thousands), or 11.1% of revenue, compared with $17,211 (in thousands), or 9.3% of revenue. However, non-GAAP EBITDA margin was 12.6% of revenue versus 13.1% a year earlier, while non-GAAP net income margin was 6.4% versus 7.3%. The quarter also included higher interest expense, net of $(2,609) (in thousands), compared with $(1,750) (in thousands).

Year-to-date revenue was $626,707 (in thousands), compared with $554,620 (in thousands), while non-GAAP EBITDA was $77,135 (in thousands), or 12.3% of revenue, compared with $72,452 (in thousands), or 13.1% of revenue. GAAP net income for the year-to-date period was $38,546 (in thousands), below $41,597 (in thousands) in the prior-year period. CRA identified portfolio optimization actions in the current year-to-date period, including $1.6 million of cash severance and $1.0 million of non-cash charges.

Cash conversion remains an important monitoring point. CRA used $(43,910) (in thousands) in operating activities year to date, versus $(37,595) (in thousands), while accounts receivable and unbilled services rose to $289,574 (in thousands). At the same time, the company repurchased $(49,303) (in thousands) of common stock and paid $11,040 (in thousands) in cash dividends and dividend equivalents. It ended the period with $20,400 (in thousands) of cash and cash equivalents, $75,000 (in thousands) on its revolving line of credit, and $72,923 (in thousands) of non-current term loan.

Management raised full-year fiscal 2026 constant-currency revenue guidance to $830 million to $840 million from the previously disclosed $805 million to $820 million range and narrowed non-GAAP EBITDA margin guidance to 12.2% to 12.8% from 12.0% to 13.0%. It expects currency to reduce reported annual revenue by approximately $2.9 million and annual EBITDA by approximately $0.4 million. CRA also raised its quarterly cash dividend 17.5% to $0.67 per common share, while flagging uncertain global macroeconomic, business, and political conditions as factors that can affect clients and the business.

Management, verbatim

CRA continues to build on its strong start to fiscal 2026 as third-quarter revenue increased 15.6% year over year to $214.9 million.

Paul Maleh, President and Chief Executive Officer

Broad-based contributions once again characterized CRA’s financial performance, reflecting both the quality and the depth of our portfolio.

Paul Maleh, President and Chief Executive Officer

Given our strong results and healthy sales pipeline, we are increasing our full-year revenue guidance and narrowing our profit margin guidance range.

Paul Maleh, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Prior-quarter comparatives were not reported for the presented operating metrics.
  • Revenue by individual practice, Legal & Regulatory offerings, Management Consulting services, North American operations, and international operations was not reported.
  • Quarter-end consultant headcount was not reported; only the 6.2% year-over-year increase was reported.
  • Quarterly operating cash flow, quarterly capital expenditures, and free cash flow were not reported.
  • Full-year fiscal 2026 guidance for gross margin, operating expenses, tax rate, GAAP net income, GAAP earnings per share, and non-GAAP earnings per share was not reported.
  • A separate previous-release outlook was not provided; therefore, no reported actual-versus-prior-guidance comparison is included.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Charles River Associates (NASDAQ: CRAI) released its Q3 2026 earnings via an SEC Form 8‑K, highlighting record revenue growth and a dividend increase.

Company-level read

Ticker impact

$CRAIBullishHigh confidence
Context

Company reported Q3 2026 results with 15.6% revenue growth and raised full-year revenue guidance to $830‑$840M.

Expected impact

likely upward pressure as investors price in stronger revenue and higher dividend.

Evidence & confidence

First‑report earnings release with material beat and guidance raise for a mid‑cap consulting firm.

Market effects

May boost sentiment for consulting and professional services sector.

Positive for US markets, especially Nasdaq‑listed service firms.

Limited to investors tracking US consulting equities.

Counterpoint

Higher guidance could be offset by macro‑uncertainty and potential margin pressure.

Key entities

  • Charles River Associates

    Consulting firm reporting Q3 results and guidance.

Every CRAI earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$CRAIHighAI 8/10

CRA International (CRAI) Q3 2026 Earnings Call Transcript

CRA International (CRAI) reported Q3 2026 revenue growth of 7% YoY, with 4 practices setting new records. Profits hit record highs despite increased expenses. Consultant headcount and utilization rose, supporting a strong sales pipeline. Legal and regulatory services revenue increased 15.7%, outpacing broader market trends. The company raised its annual revenue guidance to $830M-$840M and narrowed EBITDA margin guidance to 12.2%-12.8%.

$CRAIMed

Charles River Associates Q3 Earnings Call Highlights

Charles River Associates reported Q3 revenue growth in legal and regulatory services (15.7%) and management consulting (9.8%). Consultant headcount rose 6.2% YoY to 1,028. AI and antitrust work drove demand, though Q3 merger activity fell 41% QoQ. The company increased its dividend by 17.5% and reduced net debt to $129.6M. Non-GAAP tax rate rose to 34.9%.